Davisite will you be reviewing the program with the FDA before the first trial in Aus with RC220 to make for an easier transition to a U.S. IND and subsequent trials in the US.
If so that's fantastic
But if not how do we know RC220 and trial design will meet FDA needs?
RAC media coverage, page-2051
-
- There are more pages in this discussion • 231 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.74 |
Change
0.125(7.76%) |
Mkt cap ! $295.4M | |||
| Open | High | Low | Value | Volume |
| $1.60 | $1.76 | $1.59 | $133.5K | 79.61K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | $1.73 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.75 | 4466 | 2 |
View Market Depth
| Last trade - 14.59pm 05/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |